Skip to main content

Table 1 Healthy controls and Scleroderma patient’s data

From: The role of the oncostatin M/OSM receptor β axis in activating dermal microvascular endothelial cells in systemic sclerosis

Name Sex Age Disease duration Skin score Endothelial cells/perivascular cells Fibroblasts
HC1 F 42   +
HC2 F 28   ++ +
HC3 F 52   +
HC4 M 28   +
Diffuse SSc 1 F 62 2 years 24 ++ +
Diffuse SSc 2 F 47 1 year 15 +++ ++
Diffuse SSc 3 F 47 8 years 15 +++ ++
Diffuse SSc 4 F 72 1 year 34 ++ ++
Diffuse SSc 5 M 33 3 years 18 ++ ++
Diffuse SSc 6 M 36 7 years 35 +++ ++
Diffuse SSc 7 M 61 5 years 54 +++ ++
Limited SSc 1 F 42 2 years 3 +++ ++
Limited SSc 2 F 52 2 years 3 ++ +
Limited SSc 3 F 42 2 years 4 ++ ++
Limited SSc 4 F 68 1 year 0 + +
Limited SSc 5 F 37 1 year 2 ++ +
Limited SSc 6 F 52 5 years 16 ++ ++
Limited SSc 7 F 44 2 years 3 +++ +
Biopsies used in IF
 HC 4 F 63     
 HC 5 M 44     
 HC 6 F 50     
 Diffuse SSc 8 F 60 5 years 12   
 Diffuse SSc 9 M 62 2 months 23   
 Limited SSc 10 F 74 4 years 0   
  1. F female, M male
\